Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
IDF strikes Hamas terror base in Lebanon, Health Ministry says 11 killed - 2RFK Jr.'s handpicked vaccine panel just voted to stop recommending hepatitis B shots for all newborns. Why experts object.
- 3Surf Spot Mechanics: Bells Beach
- 4\Step by step instructions to Pick the Best Material Organization for Your Home\
- 5German hauliers warn soaring energy prices may soon impact consumers
- Step by step instructions to Boost the Eco-friendliness of Your Smash 1500.
- How mountain terraces have helped Indigenous peoples live with climate uncertainty
- The Best Computer games for Multiplayer Fun
- Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
- Scientists discover black hole flare with the light of 10 trillion suns
- Vote In favor of Your Favored Kind Of Tea
- The Main 15 Applications for Efficiency and Association
- Fundamental Archives for Beginning Your Business
- Relentless rise in carbon pollution from fossil fuels slightly dampens climate-fighting hopes
